News Releases
227 results
Other financial information
L’Oréal announces today that it has agreed to sell approximately 29.6 million of Sanofi shares to Sanofi for €101.5 per share, for a total consideration of €3 billion.
Upon completion of the transaction and cancellation of the repurchased shares, L’Oréal will own 7.2% of Sanofi’s share capital and 13.1% of its voting rights[1].
Other financial information
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA
L’Oréal successfully prices a 1.25 billion euro dual tranche bond
Sales
Solid +6% growth despite turbulences
Sales: 32.40 billion euros, +6.0% like-for-like[1], +6.0% reported.
Growth in all Divisions with L’Oréal Luxe accelerating a third consecutive quarter, Professional Products keeping the rhythm.
Acquisitions
Inside information
L’ORÉAL GROUPE ACQUIRES A 10% STAKE IN GALDERMA, THE PURE-PLAY DERMATOLOGY LEADER AND ONE OF THE WORLD’S LARGEST PLAYERS IN INJECTABLE AESTHETICS.
THIS INVESTMENT TO BE COMPLEMENTED BY A NEW STRATEGIC SCIENTIFIC PARTNERSHIP BETWEEN L’ORÉAL AND GALDERMA.
Other financial information
L’Oréal announces that it has made available to the public and filed with the Autorité des
marchés financiers its half-year financial report as of June 30, 2024.
The 2024 Half-Year Financial Report can be found on www.loreal-finance.com website in the Regulated information
section.
This report, available for consultation and downloading, includes:
Half-year results
Continued Strong Growth and Market Outperformance
Further Operating Margin Improvement
Sales: 22.12 billion euros, +7.3% like-for-like1, +7.5% reported.
Continued outperformance of the global beauty market.
Other financial information
L’Oréal today announces the launch of its fourth Employee Share Ownership Plan, allowing employees to purchase shares in L’Oréal and more closely participate in its development. In 2024, the plan will be rolled out in all countries where it is feasible (63 in total) and features enhanced accessibility for employees recently joining the Groupe.
Annual General Meeting
Annual General Meeting and
Board of Directors’ meeting of 23 April 2024
Dividend of 6.60 euros per share, increased by +10%
Appointment of Mr Jacques Ripoll as Director
Renewal of the term of office as Directors of Ms Béatrice Guillaume-Grabisch, Ms Ilham Kadri, Mr Jean-Victor Meyers and Mr Nicolas Meyers
Sales
A VERY GOOD START TO THE YEARHIGH SINGLE DIGIT RHYTHM MAINTAINED
Sales: 11.24 billion euros, +9.4% like-for-like1, +8.3% reported.
First quarter sales included a positive 130 million euro phasing impact ahead of the implementation of new IT systems in North America. Adjusted like-for-like growth amounted to a strong +8.1%.
Annual General Meeting
L’Oréal, the world’s leading beauty company, announced terms of information availability regarding the Annual General Meeting to be held on Tuesday 23 April 2024 and the 2023 Universal Registration Document.
TERMS OF INFORMATION AVAILABILITY REGARDING THE ANNUAL GENERAL MEETING OF TUESDAY 23 APRIL 2024
Since February 2022, regulated documents posted on the www.loreal-finance.com website have been secured and authenticated with the blockchain technology by Wiztrust. You can check the authenticity on the website www.wiztrust.com
